These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5350623)

  • 1. Alteration of the behavioral effects of amphetamine by agents which modify cholinergic function.
    Goldberg ME; Ciofalo VB
    Psychopharmacologia; 1969; 14(2):142-9. PubMed ID: 5350623
    [No Abstract]   [Full Text] [Related]  

  • 2. Some actions of cholinergic and anticholinergic drugs on reactive behavior.
    Herz A
    Prog Brain Res; 1968; 28():73-85. PubMed ID: 5699593
    [No Abstract]   [Full Text] [Related]  

  • 3. Methodological problems in evaluating the role of cholinergic mechanisms in behavior.
    Weiss B; Heller A
    Fed Proc; 1969; 28(1):135-46. PubMed ID: 4974735
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of centrally and peripherally acting cholinergic drugs on the short-term performance gradient following passive-avoidance training.
    Schneider AM; Kapp BS; Sherman WM
    Psychopharmacologia; 1970 Aug; 18(1):77-81. PubMed ID: 5523377
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative effects of physostigmine and neostigmine on acquisition and performance of a conditioned avoidance behavior in the rat.
    Rosecrans JA; Domino EF
    Pharmacol Biochem Behav; 1974; 2(1):67-72. PubMed ID: 4828484
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of central stimulants and depressants on mouse brain acetylcholine and choline levels.
    Consolo S; Ladinsky H; Peri G; Garattini S
    Eur J Pharmacol; 1972 May; 18(2):251-5. PubMed ID: 4402572
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of cholinergic drugs on poor performance of rats in a shuttle-box.
    Rech RH
    Psychopharmacologia; 1968; 12(5):371-83. PubMed ID: 5723186
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacology of a potential anti-Parkinson agent: tigloidine.
    Sanghvi I; Bindler E; Gershon S
    Eur J Pharmacol; 1968 Oct; 4(3):246-53. PubMed ID: 5723419
    [No Abstract]   [Full Text] [Related]  

  • 9. Hippocampal theta rhythm involvement in cholinergic-induced blockade of discriminated avoidance responding in rats.
    Erickson CK; Chalmers RK
    Arch Int Pharmacodyn Ther; 1966 Sep; 163(1):70-8. PubMed ID: 5970858
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of some drugs on the "free" and "bound" acetylcholine content of rat brain.
    Crossland J; Slater P
    Br J Pharmacol Chemother; 1968 May; 33(1):42-7. PubMed ID: 5660164
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of atropine and/or physostigmine on cerebral acetylcholine in rats poisoned with soman.
    Harris LW; Heyl WC; Stitcher DL; Moore RD
    Life Sci; 1978 Mar; 22(10):907-10. PubMed ID: 642705
    [No Abstract]   [Full Text] [Related]  

  • 12. Narcotic-antagonist analgesics: interactions with cholinergic systems.
    Harris LS; Dewey WL; Howes JF; Kennedy JS; Pars H
    J Pharmacol Exp Ther; 1969 Sep; 169(1):17-22. PubMed ID: 4389919
    [No Abstract]   [Full Text] [Related]  

  • 13. Downregulation of muscarinic- and 5-HT1B-mediated modulation of [3H]acetylcholine release in hippocampal slices of rats with fimbria-fornix lesions and intrahippocampal grafts of septal origin.
    Cassel JC; Jeltsch H; Neufang B; Lauth D; Szabo B; Jackisch R
    Brain Res; 1995 Dec; 704(2):153-66. PubMed ID: 8788910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of physostigmine and atropine on the single-trial passive avoidance response in rats.
    Jagdev N; Barar FS
    Indian J Physiol Pharmacol; 1982; 26(3):201-6. PubMed ID: 7174066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporation of exogenous acetylcholine, choline and atropine in mouse brain cortex slices.
    Schuberth J; Sundwall A
    Acta Pharmacol Toxicol (Copenh); 1967; 25():Suppl 4:75. PubMed ID: 5630966
    [No Abstract]   [Full Text] [Related]  

  • 16. Central and peripheral muscarinic actions of physostigmine and oxotremorine on avoidance responding of squirrel monkeys.
    Witkin JM
    Psychopharmacology (Berl); 1989; 97(3):376-82. PubMed ID: 2497488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atropine, an anticholinergic drug, impairs memory retrieval of a high consolidated avoidance response in mice.
    Boccia MM; Blake MG; Acosta GB; Baratti CM
    Neurosci Lett; 2003 Jul; 345(2):97-100. PubMed ID: 12821180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tremorine, physostigmine and tremor blocking drugs on brain monoamines.
    Rogers KJ; Slater P
    Arch Int Pharmacodyn Ther; 1971 Sep; 193(1):68-72. PubMed ID: 5111328
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhancement by secoverine and physostigmine of retention of passive avoidance response in mice.
    Gower AJ
    Psychopharmacology (Berl); 1987; 91(3):326-9. PubMed ID: 3104954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of cholinergic activity and the aversive threshold in the rat.
    Houser VP; Van Hart DA
    Pharmacol Biochem Behav; 1974; 2(5):631-7. PubMed ID: 4431827
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.